ArticleNeurology international2023

Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine.

Francesca Schiano di Cola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.